33
/pt/
AIzaSyB4mHJ5NPEv-XzF7P6NDYXjlkCWaeKw5bc
November 1, 2025
3512555
319423
2
Create a timeline
Public Timelines
For educational institutions For teachers For students Cabinet
For educational institutions For teachers For students Open cabinet
FAQ Receber premium
Create a timeline
Public timelines
FAQ
About & FeedbackAcordoPrivacidadeFAQ
Support 24/7  
CabinetGet premium
Donate

1 jan 2006 ano - NCI's Study of Tamoxifen and Raloxifene (STAR)

Descrição:

Results from NCI's Tamoxifen and Raloxifene study show that postmenopausal women at increased risk of breast cancer may reduce their risk of developing the disease if they take raloxifene as an antiestrogen medication. The risk of serious side effects of raloxifene is lower than that of tamoxifen.

Adicionado na linha do tempo:

Cancer

ByTrinity Ozias
14 nov 2019
0
0
300

Data:

1 jan 2006 ano
Agora
~ 19 years ago
About & FeedbackAcordoPrivacidadeFAQ
Support 24/7  
CabinetGet premium
Donate
The service accepts bank transfer (ACH, Wire) or cards (Visa, MasterCard, etc). Processed by Stripe.
Secured with SSL